Researchers at a university in eastern Zhejiang Province have used a 3D printer to create living kidneys, which are expected to be used for transplants in the future.
NEW YORK (Reuters Health) – Impaired kidney function related to treatment of childhood cancer does not recover over time, according to a Dutch study reported in Cancer Epidemiology,…
NEW YORK (Reuters Health) – A novel VEGFR inhibitor, tivozanib, improves progression-free survival significantly in patients with metastatic renal cell carcinoma but does not improve overall survival, according…
By Genevra Pittman NEW YORK (Reuters Health) – Men treated for prostate cancer with androgen deprivation therapy have a higher risk of developing kidney problems, a new study…
By David Douglas NEW YORK (Reuters Health) – Mammalian target of rapamycin (mTOR) inhibitor treatment has been linked with acute tubular necrosis (ATN) in four case reports from…
NEW YORK (Reuters Health) – Agents that target the mTOR axis, which have become particularly important in the treatment of advanced renal cell carcinoma (RCC), have significant adverse…
NEW YORK (Reuters Health) – For localized renal tumors, partial nephrectomy confers a survival advantage and a lower risk of severe chronic kidney disease (CKD) after surgery, relative…
NEW YORK (Reuters Health) – In patients with type 2 diabetes, intensive control of blood sugar reduces the risk of microalbuminuria and macroalbuminuria, but its impact on hard…
NEW YORK (Reuters Health) – Active surveillance (“watchful waiting”) of small renal masses offers short term results equivalent to those with immediate surgery, researchers from UK report in…
NEW YORK (Reuters Health) – Pooled data suggest that use of renin–angiotensin system (RAS) inhibitors, particularly angiotensin converting enzyme (ACE) inhibitors may increase the risk of angioedema, researchers…